A Multicenter, Randomized, Open-Label Trial Comparing the Efficacy and Safety of Monoclonal Anti-Rh (D) Immunoglobulin with Polyclonal Anti-Rh (D) Immunoglobulin for the Prevention of Maternal Rh-Isoimmunization

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Journal of Obstetrics and Gynecology of India

• Publication date

  2019-06-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13224-019-01234-2PMID 31598044PMCID PMC6765035
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The American College of Obstetricians and Gynecologists

  2018cited by this paper
• Practice Bulletin No. 181: Prevention of Rh D Alloimmunization.

  2017cited by this paper
• Sensitivity of Fetal RhD Screening for Safe Guidance of Targeted Anti-D Immunoglobulin Prophylaxis: Prospective Cohort Study of a Nationwide Programme in the Netherlands

  2017cited by this paper
• Prevention of Rh D Alloimmunization

  2017cited by this paper
• Antibodies to watch in 2017

  2016cited by this paper
• Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands

  2016cited by this paper
• Correlation between the Amount of Anti-D Antibodies and IgG Subclasses with Severity of Haemolytic Disease of Foetus and Newborn

  2015cited by this paper
• Anti-D administration in pregnancy for preventing rhesus alloimmunisation.

  2015influential reference
• Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.

  2015cited by this paper
• Appropriate provision of anti-D prophylaxis to RhD negative pregnant women: a scoping review

  2014cited by this paper
• Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice

  2014cited by this paper
• The importance of antenatal prevention of RhD immunisation in the first pregnancy.

  2014cited by this paper
• BCSH guideline for the use of anti‐D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn

  2014cited by this paper
• Errors in anti‐D immunoglobulin administration: retrospective analysis of 15 years of reports to the UK confidential haemovigilance scheme

  2013cited by this paper
• Anti-RhD-Mediated Immunosuppression: Can Monoclonal Antibodies Imitate the Action of Polyclonal Antibodies?

  2012cited by this paper
• Inaccurate doses of R immune globulin after rh-incompatible fetomaternal hemorrhage: survey of laboratory practice.

  2009cited by this paper
• Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti‐D immunoglobulin: more questions than answers

  2007cited by this paper

• Prophylactic Treatment and Sensitization Rates among Pregnant Rh-negative Women in India: A Second Interim Analysis of a Real-world, Prospective, Observational Study (Rhythm®)

  2025cites this paper
• Fucosylation limits ADCC in clinically used anti-RhD monoclonal antibodies.

  2025cites this paper
• Monoclonal RhD prophylaxis: high time to evaluate efficacy.

  2024cites this paper
• Anti‐D prophylaxis should protect all newborns from haemolytic disease, regardless of their country of residence

  2024cites this paper
• Fc mutagenesis enhances the functionality of anti-RhD monoclonal antibodies

  2024cites this paper
• Antibody-Mediated Antigen Loss Switches Augmented Immunity to Antibody-Mediated Immunosuppression.

  2023cites this paper
• Post-marketing safety evaluation of recombinant anti-rho (D) immunoglobulin for the prevention of maternal rh-isoimmunization: A prospective, multi-centre, phase IV study

  2023cites this paper
• FcγRIV is required for IgG2c mediated enhancement of RBC alloimmunization

  2022cites this paper
• Prophylaxis of rhesus-sensitization of pregnant women. Experience of anti-rhesus immunoglobulin Rhesogam® N using

  2021cites this paper
• IgG Subclass Determines Suppression Versus Enhancement of Humoral Alloimmunity to Kell RBC Antigens in Mice

  2020cites this paper